Hyperphosphatemia - 26 Studies Found

Completed : Dose Finding Study to Treat High Phosphate Levels in the Blood.
: Hyperphosphatemia
: 2014-03-06
:
  • Drug: AZD1722 AZD1722, oral ta
Recruiting : Study of Individualized Therapy on Hyperphosphatemia in Maintenance Hemodialysis Patients
:
  • Hyperphosphatemia
  • End-stage Renal Disease

: 2016-01-28
:
  • Other: enhanced individualised therapy

Completed : Double Blind Randomized Placebo Controlled Trial of FOSTRAP Chewing Gum in Patients With CKD and Hyperphosphatemia
:
  • Hyperphosphatemia
  • Chronic Kidney Disease

: 2010-01-25
:
  • Other: FOSTRAP Chewing Gum 20

Completed : A Phase 2 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on Hemodialysis
:
  • Hyperphosphatemia
  • Chronic Kidney Disease

: 2007-07-18
:
  • Drug: ASP1585 Oral
Completed : A Phase III, Multicentre, Double-Blind, Placebo-Controlled Withdrawal Study in Patients With Hyperphosphatemia
:
  • Chronic Kidney Disease
  • Hyperphosphatemia

: 2006-12-27
:
  • Drug: MCI-196 (Colestilan(INN), Colestimide(JAN), CHOLEBINE®)

Completed : BAY 77-1931 Long-term Extension From Phase II Study
: Hyperphosphatemia
: 2008-10-08
: Drug: BAY 77-1931 Lanthanum Carbonate (BAY 77-1931)
Completed : Dose Range-finding Study of ASP1585 in Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia
: Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia
: 2016-03-03
: Drug: ASP1585 Oral Other Names:
Completed : A Phase III Study of PA21 in Hemodialysis Patients With Hyperphosphatemia
:
  • Hemodialysis
  • Hyperphosphatemia

: 2013-05-07
:
  • Drug: PA21
  • Drug: Sevelamer hydrochloride
Completed : A Phase III Study of PA21 in Peritoneal Dialysis Patients With Hyperphosphatemia
:
  • Peritoneal Dialysis
  • Hyperphosphatemia

: 2013-05-07
: Drug: PA21
Completed : A Phase III Study of PA21 With Calcium Carbonate in Hemodialysis Patients With Hyperphosphatemia
:
  • Hemodialysis
  • Hyperphosphatemia

: 2013-05-07
: Drug: PA21
<<< Previous | Next >>>